Financials
- Market Capitalization 671.08 B
- Employee 141 K
- Founded N/A
- CEO Joaquin Duato
- Website www.jnj.com
- Headquarter New Jersey, United States
- FIGI BBG000BMHYD1
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
18.82
Relación precio/flujo de caja
5.35
Dividendos por acción
5.14
Rendimiento por dividendo, %
2.48
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 11 | LLY Eli Lilly and Company Common Stock | 1159.50 USD | -0.05% | -0.98% | -1.44% | +55.81% | 1.09 T USD | ||
| 23 | ABBV AbbVie Inc. Common Stock | 260.21 USD | -0.57% | +0.61% | +5.37% | +22.44% | 459.82 B USD | ||
| 31 | MRK Merck & Company, Inc. Common Stock | 152.34 USD | +0.41% | +4.15% | +17.72% | +81.81% | 375.85 B USD | ||
| 43 | NVS Novartis AG | 163.07 USD | +0.39% | +5.53% | +5.08% | +25.62% | 311.16 B USD |